Tysabri may be more effective than Gilenya...
Posted: Fri Oct 07, 2016 12:13 am
Tysabri may be more effective than Gilenya at reducing disease activity in MS patients, study says
An indirect comparison of results from randomised clinical trials in relapsing-remitting multiple sclerosis patients suggests that Tysabri (natalizumab) is more effective than Gilenya (fingolimod) at reducing disease activity...Read more - http://www.ms-uk.org/tysabri-may-be-mor ... ays-071016
An indirect comparison of results from randomised clinical trials in relapsing-remitting multiple sclerosis patients suggests that Tysabri (natalizumab) is more effective than Gilenya (fingolimod) at reducing disease activity...Read more - http://www.ms-uk.org/tysabri-may-be-mor ... ays-071016